CLDN1 and neoplasm: There was also no correlation between CLDN1 RMA expression and patient survival or time to tumor recurrence in 16 primary OC patients (Pearson correlation, R= 0.031, p= 0.89, and R= 0.041, p= 0.86, respectively; data not shown).